within Pharmacolibrary.Drugs.ATC.C;

model C07FB03
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 0 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 0 / 1000000,
    adminCount     = 1,
    Vd             = 0,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Combination of atenolol, a selective beta-1 adrenergic blocker, and nifedipine, a dihydropyridine calcium channel blocker. Used for the management of hypertension and angina pectoris. The drug is approved and used in clinical practice today, particularly when single-agent therapy is insufficient.</p><h4>Pharmacokinetics</h4><p>No direct pharmacokinetic studies or population PK models published for the fixed dose combination of atenolol and nifedipine (ATC C07FB03) were found. Individual pharmacokinetics for each agent are well-characterized, but specific combination PK parameters are not reported in the literature for healthy or patient populations.</p><h4>References</h4><ol><li><p>Gangji, D, et al., &amp; Herchuelz, A (1984). Study of the influence of nifedipine on the pharmacokinetics and pharmacodynamics of propranolol, metoprolol and atenolol. <i>British journal of clinical pharmacology</i> 17 Suppl 1(Suppl 1) 29S–35S. DOI:<a href=&quot;https://doi.org/10.1111/j.1365-2125.1984.tb02425.x&quot;>10.1111/j.1365-2125.1984.tb02425.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/6146337/&quot;>https://pubmed.ncbi.nlm.nih.gov/6146337</a></p></li><li><p>Fitzsimons, TJ, et al., &amp; McAinsh, J (1991). A study of the pharmacokinetics and pharmacodynamics of nifedipine in combination with atenolol. <i>Biopharmaceutics &amp; drug disposition</i> 12(1) 81–94. DOI:<a href=&quot;https://doi.org/10.1002/bdd.2510120109&quot;>10.1002/bdd.2510120109</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/2039814/&quot;>https://pubmed.ncbi.nlm.nih.gov/2039814</a></p></li><li><p>Rosenkranz, B, et al., &amp; Frölich, JC (1986). Interaction between nifedipine and atenolol: pharmacokinetics and pharmacodynamics in normotensive volunteers. <i>Journal of cardiovascular pharmacology</i> 8(5) 943–949. DOI:<a href=&quot;https://doi.org/10.1097/00005344-198609000-00010&quot;>10.1097/00005344-198609000-00010</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/2429095/&quot;>https://pubmed.ncbi.nlm.nih.gov/2429095</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end C07FB03;
